This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.
Keywords: Phosphodiesterase-5 inhibitors; Sildenafil Citrate; Tadalafil; fetus; meta-analysis; pregnancy; systematic review.
Copyright © 2021 Elsevier Inc. All rights reserved.